|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mileo AM, Mattarocci S, Matarrese P,
Anticoli S, Abbruzzese C, Catone S, Sacco R, Paggi MG and Ruggieri
A: Hepatitis C virus core protein modulates pRb2/p130 expression in
human hepatocellular carcinoma cell lines through promoter
methylation. J Exp Clin Cancer Res. 34:1402015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lombardi G, Perego S, Sansoni V and Banfi
G: Circulating miRNA as fine regulators of the physiological
responses to physical activity: Pre-analytical warnings for a novel
class of biomarkers. Clin Biochem. 49:1331–1339. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zamore PD and Haley B: Ribo-gnome: The big
world of small RNAs. Science. 309:1519–1524. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhou SL, Hu ZQ, Zhou ZJ, Dai Z, Wang Z,
Cao Y, Fan J, Huang XW and Zhou J: miR-28-5p-IL-34-macrophage
feedback loop modulates hepatocellular carcinoma metastasis.
Hepatology. 63:1560–1575. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kumar A: MicroRNA in HCV infection and
liver cancer. Biochim Biophys Acta. 1809.694–699. 2011.
|
|
8
|
Ji J, Shi J, Budhu A, Yu Z, Forgues M,
Roessler S, Ambs S, Chen Y, Meltzer PS, Croce CM, et al: MicroRNA
expression, survival, and response to interferon in liver cancer. N
Engl J Med. 361:1437–1447. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tang H, Zhang J, Yu Z, Ye L, Li K, Ding F,
Feng X and Meng W: Mir-452-3p: A Potential Tumor Promoter That
Targets the CPEB3/EGFR Axis in Human Hepatocellular Carcinoma.
Technol Cancer Res Treat. 16:1136–1149. 2017. View Article : Google Scholar
|
|
10
|
Cao J, Qiu J, Wang X, Lu Z, Wang D, Feng
H, Li X, Liu Q, Pan H, Han X, et al: Identification of microRNA-124
in regulation of Hepatocellular carcinoma through BIRC3 and the
NF-κB pathway. J Cancer. 9:3006–3015. 2018. View Article : Google Scholar :
|
|
11
|
He C, Liu Z, Jin L, Zhang F, Peng X, Xiao
Y, Wang X, Lyu Q and Cai X: lncRNA TUG1-Mediated Mir-142-3p
Downregulation Contributes to Metastasis and the
Epithelial-to-Mesenchymal Transition of Hepatocellular Carcinoma by
Targeting ZEB1. Cell Physiol Biochem. 48:1928–1941. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang L and Yu P: miR-300 promotes
proliferation and EMT-mediated colorectal cancer migration and
invasion by targeting p53. Oncol Rep. 36:3225–3232. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
He J, Feng X, Hua J, Wei L, Lu Z, Wei W,
Cai H, Wang B, Shi W, Ding N, et al: miR-300 regulates cellular
radiosensitivity through targeting p53 and apaf1 in human lung
cancer cells. Cell Cycle. 16:1943–1953. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang JQ, Chen S, Gu JN, Zhu Y, Zhan Q,
Cheng DF, Chen H, Deng XX, Shen BY and Peng CH: MicroRNA-300
promotes apoptosis and inhibits proliferation, migration, invasion
and epithelial-mesenchymal transition via the Wnt/β-catenin
signaling pathway by targeting CUL4B in pancreatic cancer cells. J
Cell Biochem. 119:1027–1040. 2018. View Article : Google Scholar
|
|
15
|
Wang R, Yu Z, Chen F, Xu H, Shen S, Chen
W, Chen L, Su Q, Zhang L, Bi J, et al: miR-300 regulates the
epithelial-mesenchymal transition and invasion of hepatocellular
carcinoma by targeting the FAK/PI3K/AKT signaling pathway. Biomed
Pharmacother. 103:1632–1642. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Shang D, Bi R, Han T, Wang D, Tian Y and
Liu Y: Expression and proliferation-promoting role of lymphoid
enhancer-binding factor 1 in human clear cell renal carcinoma.
Cancer Invest. 32:368–374. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xu S, Yang Z, Zhang J, Jiang Y, Chen Y, Li
H, Liu X, Xu D, Chen Y, Yang Y, et al: Increased levels of
β-catenin, LEF-1, and HPA-1 correlate with poor prognosis for acral
melanoma with negative BRAF and NRAS mutation in BRAF exons 11 and
15 and NRAS exons 1–2. DNA Cell Biol. 34:69–77. 2015. View Article : Google Scholar :
|
|
18
|
Bai PS, Hou P and Kong Y: Hepatitis B
virus promotes proliferation and metastasis in male Chinese
hepatocellular carcinoma patients through the
LEF-1/miR-371a-5p/SRCIN1/pleiotrophin/Slug pathway. Exp Cell Res.
370:174–188. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
20
|
Chen Z, Zhang W, Jiang K, Chen B, Wang K,
Lao L, Hou C, Wang F, Zhang C and Shen H: MicroRNA-300 regulates
the ubiquitination of PTEN through the CRL4BDCAF13 E3 ligase in
osteosarcoma cells. Mol Ther Nucleic Acids. 10:254–268. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shen Z, Li C, Zhang K, Yu W, Xiao H, Li B
and Liu T: The up-regulation of miR-300 in gastric cancer and its
effects on cells malignancy. Int J Clin Exp Med. 8:6773–6783.
2015.PubMed/NCBI
|
|
22
|
Zhou F, Li Y, Hao Z, Liu X, Chen L, Cao Y,
Liang Z, Yuan F, Liu J, Wang J, et al: MicroRNA-300 inhibited
glioblastoma progression through ROCK1. Oncotarget. 7:36529–36538.
2016.PubMed/NCBI
|
|
23
|
Yu J, Xie F, Bao X, Chen W and Xu Q:
miR-300 inhibits epithelial to mesenchymal transition and
metastasis by targeting Twist in human epithelial cancer. Mol
Cancer. 13:1212014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xue Z, Zhao J, Niu L, An G, Guo Y and Ni
L: Up-Regulation of MiR-300 promotes Proliferation and Invasion of
Osteosarcoma by Targeting BRD7. PLoS One. 10:e01276822015.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ge W, Han C, Wang J and Zhang Y: MiR-300
suppresses laryngeal squamous cell carcinoma proliferation and
metastasis by targeting ROS1. Am J Transl Res. 8:3903–3911.
2016.PubMed/NCBI
|
|
26
|
Sun L, Liu T, Zhang S, Guo K and Liu Y:
Oct4 induces EMT through LEF1/β-catenin dependent WNT signaling
pathway in hepatocellular carcinoma. Oncol Lett. 13:2599–2606.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hu Y, Guo X, Wang J, Liu Y, Gao H, Fan H,
Nong X, Yang X, Liu M, Li S, et al: A novel microRNA identified in
hepatocellular carcinomas is responsive to LEF1 and facilitates
proliferation and epithelial-mesenchymal transition via targeting
of NFIX. Oncogenesis. 7:222018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tian X, Li J, Ma ZM, Zhao C, Wan DF and
Wen YM: Role of hepatitis B surface antigen in the development of
hepatocellular carcinoma: Regulation of lymphoid enhancer-binding
factor 1. J Exp Clin Cancer Res. 28:582009. View Article : Google Scholar : PubMed/NCBI
|
